Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018121551) AZABICYCLO-SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREOF, AND APPLICATION OF SAME IN MEDICINE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/121551 International Application No.: PCT/CN2017/118784
Publication Date: 05.07.2018 International Filing Date: 27.12.2017
IPC:
C07D 401/14 (2006.01) ,C07D 405/14 (2006.01) ,A61K 31/44 (2006.01) ,A61K 31/4196 (2006.01) ,A61P 15/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
401
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
14
containing three or more hetero rings
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
405
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
14
containing three or more hetero rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4196
1,2,4-Triazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15
Drugs for genital or sexual disorders; Contraceptives
Applicants:
江苏恒瑞医药股份有限公司 JIANGSU HENGRUI MEDICINE CO., LTD. [CN/CN]; 中国江苏省连云港市 经济技术开发区昆仑山路7号 No.7 Kunlunshan Road,Economic and Technological Development Zone Lianyungang, Jiangsu 222047, CN
上海恒瑞医药有限公司 SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. [CN/CN]; 中国上海市 闵行区文井路279号 No.279 Wenjing Road, Minhang District Shanghai 200245, CN
Inventors:
李心 LI, Xin; CN
陈阳 CHEN, Yang; CN
刘涛 LIU, Tao; CN
贺峰 HE, Feng; CN
陶维康 TAO, Weikang; CN
Agent:
北京戈程知识产权代理有限公司 GE CHENG & CO., LTD.; 中国北京市 东城区东长安街1号东方广场东三办公楼19层 Level 19, Tower E3, The Towers, Oriental Plaza, No.1, East Chang An Avenue, Dongcheng District Beijing 100738, CN
Priority Data:
201611233476.528.12.2016CN
Title (EN) AZABICYCLO-SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREOF, AND APPLICATION OF SAME IN MEDICINE
(FR) DÉRIVÉ DE TRIAZOLE AZABICYCLO-SUBSTITUÉ, SA MÉTHODE DE PRÉPARATION ET SON APPLICATION EN MÉDECINE
(ZH) 氮杂双环基取代的三唑类衍生物、其制备方法及其在医药上的应用
Abstract:
(EN) The present invention relates to an azabicyclo-substituted triazole derivative, a preparation method thereof, and an application of the same in medicine. In particular, the present invention relates to a novel azabicyclo-substituted triazole derivative represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the derivative, a use thereof as a therapeutic agent, especially as an oxytocin antagonist, and a use of the same in preparing a drug for treating or preventing a disease or disorder known or shown to have beneficial effect thereon with oxytocin being suppressed. The definition of each substituent in the general formula (I) is the same as the definition in the specification.
(FR) La présente invention concerne un dérivé de triazole abicyclo-substitué, sa méthode de préparation et son application en médecine. En particulier, la présente invention concerne un nouveau dérivé de triazole azabicyclo-substitué représenté par la formule générale (I), sa méthode de préparation, une composition pharmaceutique contenant le dérivé, son utilisation en tant qu'agent thérapeutique, en particulier en tant qu'antagoniste de l'ocytocine, et une utilisation de celui-ci dans la préparation d'un médicament pour le traitement ou la prévention d'une maladie ou d'un trouble, le dérivé étant connu pour ou ayant démontré avoir un effet bénéfique sur la maladie ou le trouble avec l'ocytocine supprimée. La définition de chaque substituant dans la formule générale (I) est la même que celle qui figure dans la spécification.
(ZH) 涉及氮杂双环基取代的三唑类衍生物、其制备方法及其在医药上的应用。具体而言,涉及一种通式(I)所示的新的氮杂双环基取代的三唑类衍生物、其制备方法及其含有该衍生物的药物组合物及其作为治疗剂,特别是作为催产素拮抗剂的用途和在制备用于治疗或预防已知或可显示抑制催产素会产生有益效应的疾病或病症的药物中的用途,其中通式(I)的各取代基与说明书中的定义相同。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)